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Perspectives on ART adherence among Zambian adults living with HIV: 





The roll-out of anti-retroviral treatment (ART) has improved the survival of 
people living with HIV in Sub-Saharan Africa, and also produced  changes in 
health and functioning that are experienced alongside ART.  Disability 
frameworks, including the WHO International Classification of Functioning 
Disability and Health (ICF) and the Episodic Disability Framework (EDF), can 
illuminate helpful questions and solutions for long-term HIV management.   
The qualitative longitudinal Sepo Study (Sepo, meaning hope) was conducted 
using a disability lens to understand life on ART. The study followed 35 
people (18 women, 17 men) living with HIV and on ART 6 months or longer 
and recruited through private and public health facilities in Lusaka, Zambia 
over an 18-month period between 2012-2015. A total of 99 in-depth interviews 
were conducted.  This analysis focused on participants’ narratives regarding 
body function and ART adherence during the research period and what made 
challenges better or worse, including access to services. Conventional 
content analysis and NVIVOv10 were applied to analyse the experience of 
participants. 
Participants in this study did not report any major challenges with adherence. 
Three main themes emerged from the data related to adherence.  Firstly, ART 
was regarded as “giving life,’ which underscored adherence. Secondly, all 
participants described living strategies for adhering to ART despite health and 
functional limitations. Participants self-managed what they attributed as side-
effects or chronicity through developing low-cost strategies to support 
adherence.  For example, if dizziness was experienced, participants moved 
administration of medication towards night time. Beyond self-management 
there was a lack of support. Thirdly, participants described experiences of 
uncertainty, including the  efficacy of new regimens, potential loss of 
functioning, risk of new health problems, and death.   
Long-term ART adherence support for people living with HIV in Sub-Saharan 
Africa needs to address upcoming functional limitations. Integrating 
rehabilitation approaches could facilitate this shift in health systems and 
strengthen both self-management and health service support.  
 
Keywords 





Anti-retroviral treatment (ART) is now widely available in Sub-Saharan Africa 
(UNAIDS, 2013a), and it has become more critical to assess the challenges 
and opportunities experienced while living with chronic HIV and adhering long 
term to ART. The new global development strategies advanced in the 2016-
2030 Sustainable Development Goals, adopted by all United Nations member 
states in 2015, include a continued focus on addressing priority health issues 
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(Open Working Group of the General Assembly on Sustainable Development 
Goals, 2015) and ending AIDS by 2030 (UNAIDS, 2014, 2015). Despite 
recent advances, HIV remains a priority health concern in Sub-Saharan 
Africa. With widespread access to ART just over a decade old, the need to 
support people to remain on ART long term with undetectable viral loads is 
key to ending AIDS in the region (UNAIDS, 2014, 2015). We are only 
beginning to understand if, and how, people regain quality of life, the long-
term health challenges and the living strategies they develop to live with 
chronic HIV and adhere long term to ART. Adherence to treatment is crucial 
for the long-term success of the roll out of ART. One of the first systematic 
review using observational studies of HIV treatment programs reveals that 
retention to ART in Africa was only 65% after 36 month and that this may 
even further drop thereafter (Fox & Rosen, 2013)]. The high attrition rate was  
even worse for cohorts enrolled after 2008 when intensive efforts were 
undertaken to roll-out antiretrovirals in Africa [12]. In response countries now 
follow focused efforts to improve enrolment, uptake and adherence to ART 
most predominately advocated in the UNAIDS 90:90:90 targets (UNAIDS, 
2014). Currently a number of known adherence challenges are addressed 
such as transportation, accessibility and stigma. However we do not fully 
understand if and how other challenges such as disability may impact 
adherence to  ART (Carpenter, Hanass-Hancock, & Myezwa, 2019). 
 
A number of disabling conditions result from living with chronic HIV, yet this is 
less frequently discussed in the literature (J Hanass-Hancock, Regondi, Van 
Egeraat, & Nixon, 2013; S. A. Nixon, Hanass-Hancock, Whiteside, & Barnett, 
2011). These conditions arise as a result of the virus itself (e.g. HIV dementia) 
(Rackstraw, 2011), the side effects of treatment (e.g. peripheral neuropathy, 
pain) (Farrant et al., 2014; Meintjes et al., 2012), fragility and aging, (UNAIDS, 
2013b) and the long-term effects of coinfection and comorbidities (e.g. 
tuberculosis) (Petersen, Hancock, Bhana, Govender, & Mental Health Care, 
2013; Sherr, Clucas, Harding, Sibley, & Catalan, 2011; Smart, 2009). While 
some of these conditions have decreased in frequency or intensity with 
improved access to ART, others have increased as people survive longer on 
ART (Banks, Zuurmon, Ferrana, & Kuper, 2015; J Hanass-Hancock et al., 
2013).  
 
Recent research in South Africa suggests that HIV-related disability is 
experienced by a significant number of people on ART.  In these studies, a 
large proportion (ranging from 35.5-86%) of people on ART reported functional 
limitations which can be understood as mild to moderate disability (Carey, 
Stein, Zungu-Dirwayi, & Seedat, 2003; J. Hanass-Hancock, Myezwa, & 
Carpenter, 2015; Kietrys et al., 2019; Myezwa, Hanass-Hancock, Pauts, 
Rulaine, & Carpenter 2016). These limitations were also associated with 
depressive symptoms and negative livelihood outcomes (J. Hanass-Hancock, 
Misselhorn, Carpenter, & Myezwa, 2017; J. Hanass-Hancock, Myezwa, & 
Carpenter, 2015; Myezwa et al., 2016). For the first time, these pilot studies 
also investigated if functional limitations impact ART adherence, indicating a 
negative association (Carpenter et al., 2019). In addition, the Episodic Disability 
Framework (EDF) demonstrated that disability is experienced episodically by 
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those living with HIV and associated with uncertainty (O'Brien, Davis, Strike, 
Young, & Bayoumi, 2009).  
 
The purpose of this qualitative study was to understand if and how health 
challenges and functional limitations/disability impact treatment adherence 




The SEPO II study [43] is a qualitative longitudinal study of thirty-five adults 
(18 years and older) living with HIV, on ART for 6 months or longer, in two 
study sites in Lusaka, Zambia (one public and one private health care facility). 
The sites were chosen for their longstanding histories of ART care, and to 
facilitate access to participants who met the following inclusion criteria. 
Participants were purposely recruited for variation in sex, age, time on and 
whether they received their ART care from a public or private facility (ref). 
They were informed about the study in writing and verbally. Participation was 
voluntary and an informed consent form was signed before the first interview.  
  
Three rounds of qualitative interviews, approximately 6 months apart were 
conducted between December 17, 2012 to April 17, 2015. The interview guide 
was structured according to the domains in the World Health Organization’s 
International Classification of Function, Disability and Health (ICF) and the 
Episodic Disability Framework (EDF) developed by O’Brien et al. Both 
frameworks prompted participants to discuss how living with chronic HIV 
affects their health and functioning. The ICF also considers environmental and 
personal contextual factors related to emerging challenges; whereas the 
O’Brien framework draws attention to experiences of episodic disability and 
uncertainty.  
 
Interviews were conducted in English, Bemba and/or Nyanja depending on 
the preference of the participant, audio recorded and transcribed and 
translated into English. Each interview transcript was coded independently by 
2 members of the research team using thematic content analysis, the DEPICT 
method (Flicker & Nixon, 2014) and employing NVivo10© software as a data 
management tool (ref). The DEPICT model guides qualitative analysis through a 
collaborative and democratic approach enhancing rigour through inclusion of diverse 
team members. It uses six sequential steps namely: dynamic reading, engaged codebook 
development, participatory coding, inclusive reviewing/summarising, collaborative 
analysing and translating (Flicker & Nixon, 2014). 
 
The study received ethical approvals from the University of Toronto, Canada; 
University of Zambia, Zambia; McMaster University, Canada; and the 
University of KwaZulu-Natal, South Africa. Additional administrative approvals 







Thirty-five men and women participated in a total of 99 in-depth interviews from 
2012-2015 (Table 1). Thirty-one participants completed all 3 interviews. All 
participants had been on ART for several years and been exposed to different 
ART regimes. Half of the participants changed to Atripla over the period of the 
investigation. Atripla is a combination of efavirenz, emtricitabine and tenofovir. 
It has less site effects and needs to be applied only once a day, which has 
simplified adherence to ART (Bijker et al., 2017). 
 
Insert table 1 Participant Demographics 
 
Three themes emerged from the finding: (1) Adherence to ART is “giving life”; 
(2) Living strategies for adhering to ART; and (3) Uncertainty and adherence. 
 
Theme 1: Adherence to ART is ‘Giving Life’ 
 
Throughout the interviews participants emphasized their commitment to ART. 
ART was described as “what gives us life”, what has “added days to life” and 
that they would “not be here” without it.  
 
"I know that it [ARVs] is my life because if it was not for the medicine I would 
not be here so I do not think about it, I just take it." (53 year old woman, 8 years 
on ART)  
 
Participants reported improved health, wellbeing and quality of life since they 
initiated ART. They described feeling “strong, healthy and being able to support 
the family”.  
 
"… without ARVs I would not be where I am today, I feel good because of ARVs, 
they have helped me to recover since 2004. My body can do any kind of work 
… that is what is making me feel nice, my body is back to normal." (44 year old 
man, 8 years on ART)   
 
Living with chronic HIV and its medication was often perceived as having 
become part of life and compared to “having become like food” or “shaving 
cream”, which participants described as taking without “second thoughts”. 
Hence, ART was perceived by the study participants as being an integral part 
of their life (“that this is my life”), personal identity, and participants expressed 
a feeling of ‘normalisation’. 
 
“I think ARVs to me have become part of my life, they have become part of who 
I am right now" (51 year old man, 12 years on ART)  
 
Theme 2: Living Strategies for Adhering to ART  
 
Participants experienced health issues, which challenged adherence to ART. 
Some participants attributed challenges directly to the side effects of HIV. In 
order to manage these challenges and loss of functioning participants identified 
the need for ‘acceptance’, which appeared to motivate adherence. They also 




Participants described memory impairment, weakness, mental health and 
emotional challenges and reduced mobility and attributed these to side effects 
of ART. Participants also described co-morbidities such as stroke and 
tuberculosis and those impacted functioning. Many coping strategies were 
specific to the participant’s goals and situation.  For instance, one participant 
found he could manage his headaches by avoiding walking in the sun. One 
woman explained that her feet felt “like something has pricked it” and that she 
tried to make “sure the house is clean and she can walk with her bare feet” to 
minimize these sensations. 
  
They described how changes in appearance such as a “sunken face”, “putting 
on weight” and “distortion of their body shape” affected their acceptance by 
others and could influence their daily activities. Despite this, participants were 
committed to treatment. Participants reinforced that these challenges would 
“not stop them from taking their medication” as stopping would “create more 
problems” for them.  These participants perceived their health challenges as 
“manageable”. Some participants chose to exercise to counteract their 
concerns of “putting on weight”, “distorting of their body shape” or having lost 
body strength. 
 
Approximately one-half of the participants changed their ART regime to Atripla 
over the 18 months of our study and then reported different challenges such as 
dizziness and sleepiness Participants managed this through taking their 
medication in the evening after they had eaten and before they went to sleep. 
 
“I would feel dizzy after taking medicine I was taking the medicine at 19:00 
hours... So when I want to eat I would feel dizzy and sleep … That is how I 
changed at home I started taking it around 20:00 hours after I eat around 
19:00". (32 year old woman, 2 years on ART) 
 
Some participants also described issues of memory loss or forgetfulness, which 
could lead to missing medication. Participants developed strict routine in their 
lives to ensure that they would adhere to treatment. They also used cell phones 
and alarm systems to assist as reminders or co-opted family member to provide 
support. 
 
"I would forget … especially in the morning, that is when I would forget, before 
they put me on Atripla I would forget 8:00 hours by the time am coming to 
remember it is 09:00 hours I have not taken medicine … what I used is this 
small phone, you can set the alarm " (33 year old woman, 6 years on ART) 
 
Shifting medication adherence to the evening did not work for everyone. 
Several men noted there were gender specific expectations related to 
socializing in the evening hours which challenged adherence. On man noted 
that taking medication in the evening to avoid drowsiness was difficult because 
a “man cannot manage to sleep at 20.00, we have a lot of things to do”. Several 
men had made lifestyle adjustments and had stopped socialising through 




Participants did not discuss their functional limitations, described above, with 
their health care providers and rather evaluated the seriousness of a problem, 
if perceived as manageable they would try to deal with it by themselves. For 
instance, one man who was experiencing fatigue, sweating and forgetfulness 
which he related to his new ART explained that he did not report these changes 
to the doctor as there were many people at the clinic and he would only report 
“a serious problem”.  
 
Theme 3: Uncertainty and ART 
  
While participants were very committed to adhering to their medication they 
also expressed uncertainties related to the effectiveness of ART over time, 
including the possibility of medication shortages, worsening side effects or new 
side effects if they were to change treatment regimens. 
  
One woman described how she felt that she was living “a borrowed life”. She 
worried about the uncertainty of future health challenges. She stated that “… 
we don't know where we are going to, since we started ARV’s, it has been long 
so we don't know the impact in the future” (49 year old woman, 9 years on ART) 
  
Another woman shared her worries that the medication could “stop working”. 
She explained that “people say you take this medicine for 10 years and then 
you die”. 
  
Worries of uncertainty and health changes also impacted decisions of altering 
medication. Two participants indicated that they had refused to change their 
ART regime because of worries about the side effects a new medication might 
bring. One expressed it in the following way: 
  
The drugs “maybe they will change me … will make me worse … Atripler it has 
caused people a lot of problems … they complain that they have sleepless 
nights, there are a lot of dreams even men they have stopped functioning from 
I mean their bodies, their manhood”. 
  
These concern also led some participants to avoid discussions with a health 
provider, including discussing experiences of side effects, as they expressed a 
fear of “something else to happen” when there was a change in medication. 
  
Worries and uncertainties were also related to reoccurring thoughts of being 
still at risk of death, degrading health or loss of functioning. “Going to the clinic 
and meeting other patients” was seen as “reassuring that the disease does not 





This paper demonstrates that living long-term with HIV while using ART is 
accompanied by new health challenges and functional limitations, 
compensating living strategies and uncertainties, that are addressed mostly by 




Participants recognized the life affirming aspects of ART and adhered to ART 
in spite of the health and social challenges that they associated with their 
disease, regimens or additional health conditions. Results highlight how 
participants tried to self-manage and make adjustments to accommodate these 
challenges.  Participants were largely supported by their family and friends and 
not professional support through services related to rehabilitation or mental 
health. Therefore, participants mostly implemented known lifestyle adjustments 
or utilised technology. Some participants avoided changing their regimes due 
to uncertainties. None of them reported discussing their issues of functional 
limitations with their health practitioner or tried to access rehabilitative or other 
allied health services. Participant rather shared the notion of “needing to 
accept” as crucial to keep being committed to ART. 
 
Challenges to adhere to ART amongst people living with HIV in Sub-Saharan 
Africa have been documented in the literature and current efforts focus on 
improving adherence to ART (UNAIDS, 2014, 2015) and addresses several 
challenges related to reduce pill burdens, access to ART and overcoming 
stigma (Bijker et al., 2017). As a result, innovative approaches such as 
adherence clubs and alternative ways of dispensation have become part of the 
tool box used by health care providers in recent years.  
 
However, less is known about functional limitations and adherence. One 
previous cross-sectional study indicated that functional limitations may be 
negatively associated to ART adherence (Carpenter et al., 2019). Participants 
in our study, all of whom had been on ART for at least six months, did not reveal 
serious challenges with adherence as they were committed and had accepted 
additional challenges as part of living long term with HIV. Through multiple 
interviews we convey that this sample of participants is very committed to their 
treatment but that they still experience other health and functional challenges. 
Strategies to address functional limitations are not widely discussed in the 
literature, yet rehabilitation approaches can be used to mitigate these 
limitations (ref). There is an emerging literature describing functional limitations 
experienced while taking ART, however there is little available concerning 
coping mechanisms for these functional limitations and how these link to ART 
adherence (Carpenter et al., 2019; J. Hanass-Hancock, Myezwa, Nixon, & 
Gibbs, 2015; J Hanass-Hancock et al., 2013). In addition, literature shows that 
the experiences of functional limitation among people living with HIV when on 
ART runs the risk of being overlooked, because these issues are not sees as 
“clinical important”(Renju et al., 2017). As a result, mitigating services such as 
rehabilitation or mental health interventions are likely to be forgotten in HIV care 
and treatment. 
 
However, the WHO Consolidated ART Guidelines (World Health Organisation, 
2016) use the term patient-centred approach and mention the need to integrate 
rehabilitation into HIV-care. Nevertheless, most countries HIV-guidelines and 
strategic plans are silent on the integration of rehabilitation services. Indeed, 
Zambia’s current antiretroviral treatment guidelines (2016) and National AIDS 
Strategic Plan 2017-2021 both do not mention rehabilitation or HIV-related 
functional limitations/disability at all (Ministry of Health of the Republic of 
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Zambia, 2016a, 2016b). Research assessing how to integrate rehabilitation that 
addresses HIV-related disability in Africa is scarce. The existing studies 
suggest that elements of rehabilitation interventions can be delivered safely and 
feasible in these settings. Two studies looking at delivering structured physical 
exercise programmes for people living with HIV in South Africa (Lay, Leach, 
Barrio, & Bassett, 2015; Ross, Hellen, van Aswegen, & Musenge, 2014) 
revealed positive effects on functionality. These studies also revealed the 
barriers to physical activity which included low levels of energy, stress levels, 
family responsibilities, crime and violence, weather conditions, availability or 
parks and social activities (Roos, Myezwa, & van Aswegen, 2015) and access 
to appropriate nutrition (Lay et al., 2015). Another RCT using home-based 
rehabilitation for people with mobility limitations in South Africa (Cobbing, 
Hanass-Hancock, & Myezwa, 2016) revealed that giving information about 
functioning and how to counteract functioning was enough to initiate change of 
mild to moderate limitations. Hence, the provision of information to improve self-
management of functional limitations might be a potential feasible intervention 
considering these results as well as our participants reliance of self-
management. 
 
The negative impact of uncertainties about medication shortages and lack of 
social support have been discussed as barriers to ART adherence by other 
authors and some innovative methods of medication delivery have been 
developed in recent years (Tshuma et al., 2017; Tsondai et al., 2017). We are 
hopeful therefore that these worries will be addressed over the next decade. 
Similarly, this study revealed how social support, reliable health services and 
sensitive health care staff are crucial for ART adherence. In the Southern 
African region, remote delivery of ART medication through local facilities and 
adherence clubs has been explored as feasible solutions to these challenges, 
with current studies indicating positive results on adherence (Tshuma et al., 
2017; Tsondai et al., 2017). However, these models of delivery will not 
adequately address new health challenges that are experienced over a lifetime 
on ART.  Hence more research focusing on how to integrate HIV and 
rehabilitation services in Africa is needed. 
 
This research is limited in that it is based on a small number of people living 
with HIV who are successfully adhering to ART.  There is a need to also explore 
the experiences of those who are not able to adhere to their ART regimes as a 
result of health challenges. We argue that to more comprehensively support 
people living with HIV in the long term, the subtle experiences that underlie ART 
adherence need to be directly addressed by health systems. Rehabilitation is 
one pillar that could assist people living with HIV to not only survive but also 
thrive.   
 
Conclusions 
This study demonstrated the application of disability-related frameworks - for 
understanding experiences of living on ART. Using the ICF and EDF, we 
previously described  functional limitations among people living with HIV (S A 
Nixon et al., 2018). This paper illuminated how functional limitations may link to 




The study showed us that people who are committed to ART and live long term 
with chronic HIV are still experiencing new health related challenges, functional 
limitations and worries about uncertainties. Although these don't impact ART 
adherence necessarily, long-term adherence support for people living with HIV 
in Sub-Saharan Africa needs to address the upcoming functional limitations. 
Rehabilitation is key to achieving this. Future research should investigate how  
rehabilitation approaches can be integrated into HIV care and existing health 
systems and through this strengthen both self-management and potentially 
ART adherence.  
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Table 1: Participant Demographics 







Age (years) mean: 40.3  
range: 21-56 years 
mean: 42.9 













mean: 5.2 years 
3-12 years 




Language 4 English 
15 Nyanja 




9 Bemba 9 Bemba 
 
 
 
